Exact Mass: 547.1308

Exact Mass Matches: 547.1308

Found 73 metabolites which its exact mass value is equals to given mass value 547.1308, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

dTDP-4-amino-4,6-dideoxy-alpha-D-glucose

dTDP-4-amino-4,6-dideoxy-D-glucose; dTDP-4-amino-4,6-dideoxy-alpha-D-glucose; dTDP-viosamine; dTDP-4-amino-4,6-dideoxy-alpha-D-glucopyranose

C16H27N3O14P2 (547.0968)


   

dTDP-3-amino-3,6-dideoxy-D-glucose

dTDP-3-amino-3,6-dideoxy-D-glucose

C16H27N3O14P2 (547.0968)


   
   

dTDP-madurosamine

dTDP-madurosamine; dTDP-4-amino-3-methyl-4-deoxy-alpha-D-ribopyranose

C16H27N3O14P2 (547.0968)


   

Doxazosin mesylate

Doxazosin mesylate

C24H29N5O8S (547.1737)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Doxazosin mesylate (UK 33274) is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors.

   

dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose

dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose

C16H27N3O14P2 (547.0968)


   
   

dTDP-4-amino-4,6-dideoxy-alpha-D-galactose

dTDP-4-amino-4,6-dideoxy-alpha-D-galactose

C16H27N3O14P2 (547.0968)


   

dTDP-(3R)-amino-3,6-dideoxy-D-glucose

dTDP-(3R)-amino-3,6-dideoxy-D-glucose

C16H27N3O14P2 (547.0968)


   

(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-[glucosyl-(1->4)-b-D-glucoside]

2-(5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)acetic acid

C22H29NO15 (547.1537)


(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-[glucosyl-(1->4)-b-D-glucoside] is found in cereals and cereal products. (S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-[glucosyl-(1->4)-b-D-glucoside] is a constituent of rice bran Constituent of rice bran. (R)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-[glucosyl-(1->4)-glucoside] is found in cereals and cereal products.

   

Edoxaban

N-(5-chloropyridin-2-yl)-N-[4-(dimethylcarbamoyl)-2-{5-methyl-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridine-2-amido}cyclohexyl]ethanediamide

C24H30ClN7O4S (547.1768)


   

3-[4-[6-(beta-D-glucopyranosyloxyuronic acid)-1-methyl-1H-benzimidazol-2-ylmethoxy]phenyl]-2-methylthiopropionic amide

3-[4-[6-(beta-D-glucopyranosyloxyuronic acid)-1-methyl-1H-benzimidazol-2-ylmethoxy]phenyl]-2-methylthiopropionic amide

C25H29N3O9S (547.1624)


   

methyl (2S)-6-[(beta-D-glucopyranosyl)oxy]-2,3-dihydro-5-hydroxy-1-[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]-1H-indole-2-carboxylate|oleracein F

methyl (2S)-6-[(beta-D-glucopyranosyl)oxy]-2,3-dihydro-5-hydroxy-1-[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]-1H-indole-2-carboxylate|oleracein F

C26H29NO12 (547.169)


   

10-beta-glucopyranose-12-glutamyl-1-hydroxylethanyl-beta-carboline-3-carboxylate|tunicoidine A

10-beta-glucopyranose-12-glutamyl-1-hydroxylethanyl-beta-carboline-3-carboxylate|tunicoidine A

C25H29N3O11 (547.1802)


   
   
   

Cys Cys His Trp

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C23H29N7O5S2 (547.1672)


   

Cys Cys Trp His

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H29N7O5S2 (547.1672)


   

Cys His Cys Trp

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C23H29N7O5S2 (547.1672)


   

Cys His Trp Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C23H29N7O5S2 (547.1672)


   

Cys Trp Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H29N7O5S2 (547.1672)


   

Cys Trp His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C23H29N7O5S2 (547.1672)


   

His Cys Cys Trp

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C23H29N7O5S2 (547.1672)


   

His Cys Trp Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C23H29N7O5S2 (547.1672)


   

His Trp Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C23H29N7O5S2 (547.1672)


   

Trp Cys Cys His

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C23H29N7O5S2 (547.1672)


   

Trp Cys His Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C23H29N7O5S2 (547.1672)


   

Trp His Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C23H29N7O5S2 (547.1672)


   

(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-[glucosyl-(1->4)-b-D-glucoside]

2-(5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)acetic acid

C22H29NO15 (547.1537)


   
   
   

edoxaban

edoxaban

C24H30ClN7O4S (547.1768)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AF - Direct factor xa inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173067 - Direct Factor Xa Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Cefyl

Cefetamet pivoxil hydrochloride

C20H26ClN5O7S2 (547.0962)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

N-7-(2-(Nitrophenyldithio)ethyl)mitomycin C

N-7-(2-(Nitrophenyldithio)ethyl)mitomycin C

C23H25N5O7S2 (547.1195)


D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D008937 - Mitomycins

   

Edoxaban Isomer (RSS)

Edoxaban Isomer (RSS)

C24H30ClN7O4S (547.1768)


   

Edoxaban Isomer (SSS)

Edoxaban Isomer (SSS)

C24H30ClN7O4S (547.1768)


   

Edoxaban Isomer (RRR)

Edoxaban Isomer (RRR)

C24H30ClN7O4S (547.1768)


   

PD 166285 dihydrochloride

PD 166285 dihydrochloride

C26H28Cl3N5O2 (547.1308)


   

Fosravuconazole

Fosravuconazole

C23H20F2N5O5PS (547.0891)


D - Dermatologicals > D01 - Antifungals for dermatological use > D01B - Antifungals for systemic use > D01BA - Antifungals for systemic use C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

Bosutinib Monohydrate

Bosutinib Monohydrate

C26H31Cl2N5O4 (547.1753)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

dTDP-3-amino-3,6-dideoxy-alpha-D-glucose

dTDP-3-amino-3,6-dideoxy-alpha-D-glucose

C16H27N3O14P2 (547.0968)


   

Trimethylcetylammonium pentachlorophenate

Trimethylcetylammonium pentachlorophenate

C25H42Cl5NO (547.1709)


   

N-[5-[2-(2,3-dimethylanilino)-2-oxoethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-4-morpholin-4-ylsulfonylbenzamide

N-[5-[2-(2,3-dimethylanilino)-2-oxoethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-4-morpholin-4-ylsulfonylbenzamide

C23H25N5O5S3 (547.1018)


   

3-[(12Z,16Z)-5,20-bis(ethenyl)-4,9,15,19-tetramethyl-2-oxa-23-aza-21,22,24-triazanidapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1(20),3,5,7,9,11(23),12,14,16,18-decaen-10-yl]propanoic acid;iron(3+)

3-[(12Z,16Z)-5,20-bis(ethenyl)-4,9,15,19-tetramethyl-2-oxa-23-aza-21,22,24-triazanidapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1(20),3,5,7,9,11(23),12,14,16,18-decaen-10-yl]propanoic acid;iron(3+)

C30H27FeN4O3 (547.1432)


   

pelargonidin 3-O-(6-O-malyl-beta-D-glucoside)

pelargonidin 3-O-(6-O-malyl-beta-D-glucoside)

C25H23O14- (547.1088)


   

dTDP-4-amino-4,6-dideoxy-D-galactose

dTDP-4-amino-4,6-dideoxy-D-galactose

C16H27N3O14P2 (547.0968)


   

N(epsilon)-GMP-N(alpha)-acetyl-L-lysine methyl ester

N(epsilon)-GMP-N(alpha)-acetyl-L-lysine methyl ester

C19H30N7O10P (547.1792)


   

6-O-molonyltectoridin

6-O-molonyltectoridin

C25H23O14- (547.1088)


   

8-chloro-6-O-(6-O-malonyl)-beta-D-glucoside-2-(2-phenylethyl)chromone

8-chloro-6-O-(6-O-malonyl)-beta-D-glucoside-2-(2-phenylethyl)chromone

C26H24ClO11- (547.1007)


   

[(2S,3R,4S,5R,6R)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl] [hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate

[(2S,3R,4S,5R,6R)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl] [hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate

C16H27N3O14P2 (547.0968)


   
   

7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C22H23N6O7S2+ (547.107)


   

N-(5-acetamido-6-methoxy-6-oxohexyl)-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid

N-(5-acetamido-6-methoxy-6-oxohexyl)-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid

C19H30N7O10P (547.1792)


   

[4-(Diphenylmethyl)-1-piperazinyl]-[5-thiophen-2-yl-7-(trifluoromethyl)-3-pyrazolo[1,5-a]pyrimidinyl]methanone

[4-(Diphenylmethyl)-1-piperazinyl]-[5-thiophen-2-yl-7-(trifluoromethyl)-3-pyrazolo[1,5-a]pyrimidinyl]methanone

C29H24F3N5OS (547.1654)


   

1-[[(6R,7R)-2-Carboxy-7-[[2-[(Z)-(2-hydroxy-2-oxo-1,1-dimethylethoxy)imino]-2-(2-aminothiazole-4-yl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]octane-2-ene]-3-ylmethyl]pyridinium

1-[[(6R,7R)-2-Carboxy-7-[[2-[(Z)-(2-hydroxy-2-oxo-1,1-dimethylethoxy)imino]-2-(2-aminothiazole-4-yl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]octane-2-ene]-3-ylmethyl]pyridinium

C22H23N6O7S2+ (547.107)


   

thymidine 5-[3-(4-amino-4,6-dideoxy-D-glucopyranosyl) dihydrogen diphosphate]

thymidine 5-[3-(4-amino-4,6-dideoxy-D-glucopyranosyl) dihydrogen diphosphate]

C16H27N3O14P2 (547.0968)


   

2-[4-(2,3-Dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine methanesulfonate

2-[4-(2,3-Dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine methanesulfonate

C24H29N5O8S (547.1737)


   

(7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C22H23N6O7S2+ (547.107)


   

(3S)-4-(3-bromophenyl)-2-[(S)-tert-butylsulfinyl]-N-cyclohexyl-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

(3S)-4-(3-bromophenyl)-2-[(S)-tert-butylsulfinyl]-N-cyclohexyl-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C26H34BrN3O3S (547.1504)


   

8-[(3-Chloro-1-benzothiophen-2-yl)methyl]-9-cyclopropyl-10-[4-(hydroxymethyl)phenyl]-3,5-dioxo-4,8-diazatricyclo[5.2.2.02,6]undec-10-ene-4-carboxamide

8-[(3-Chloro-1-benzothiophen-2-yl)methyl]-9-cyclopropyl-10-[4-(hydroxymethyl)phenyl]-3,5-dioxo-4,8-diazatricyclo[5.2.2.02,6]undec-10-ene-4-carboxamide

C29H26ClN3O4S (547.1332)


   

(3R)-4-(3-bromophenyl)-2-[(R)-tert-butylsulfinyl]-N-cyclohexyl-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

(3R)-4-(3-bromophenyl)-2-[(R)-tert-butylsulfinyl]-N-cyclohexyl-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C26H34BrN3O3S (547.1504)


   

beta-D-GlcpNAc-(1->4)-alpha-D-Glcp2Ac6SOPr

beta-D-GlcpNAc-(1->4)-alpha-D-Glcp2Ac6SOPr

C19H33NO15S (547.1571)


   

[(2R,3R,4S,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-2-propoxy-6-(sulfooxymethyl)oxan-3-yl] acetate

[(2R,3R,4S,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-2-propoxy-6-(sulfooxymethyl)oxan-3-yl] acetate

C19H33NO15S (547.1571)


   

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] (2E,4E)-5-(1,3-benzodioxol-5-yl)penta-2,4-dienoate

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] (2E,4E)-5-(1,3-benzodioxol-5-yl)penta-2,4-dienoate

C22H22N5O10P (547.1104)


   

Cefetamet pivoxil hydrochloride

Cefetamet pivoxil hydrochloride

C20H25N5O7S2. HCl (547.0962)


   

(21r)-12-(3,4-dihydroxyphenyl)-7,21-dihydroxy-8,16,17,18-tetramethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17-octaen-3-one

(21r)-12-(3,4-dihydroxyphenyl)-7,21-dihydroxy-8,16,17,18-tetramethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17-octaen-3-one

C29H25NO10 (547.1478)


   

(8s)-8-{[(3e)-4-(4-hydroxy-3-methoxyphenyl)-2-oxobut-3-en-1-yl]sulfanyl}-6,15,16-trimethoxy-11-oxa-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,13,15-heptaen-12-one

(8s)-8-{[(3e)-4-(4-hydroxy-3-methoxyphenyl)-2-oxobut-3-en-1-yl]sulfanyl}-6,15,16-trimethoxy-11-oxa-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,13,15-heptaen-12-one

C29H25NO8S (547.1301)


   

2-({[(10s,11r,12r,13r,15r)-3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl]oxy}methyl)prop-2-enenitrile

2-({[(10s,11r,12r,13r,15r)-3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl]oxy}methyl)prop-2-enenitrile

C24H21NO14 (547.0962)


   

3-{[7-benzoyl-4,9-bis(c-hydroxycarbonimidoyl)-5-methyl-10h-phenazin-1-yl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

3-{[7-benzoyl-4,9-bis(c-hydroxycarbonimidoyl)-5-methyl-10h-phenazin-1-yl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

C27H25N5O6S (547.1525)


   

methyl 5-hydroxy-1-[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylate

methyl 5-hydroxy-1-[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylate

C26H29NO12 (547.169)


   

[(2r,5s)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy([hydroxy([(2r,3s,5r)-3-hydroxy-5-(4-hydroxy-5-methyl-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy)phosphoryl]oxy)phosphinic acid

[(2r,5s)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy([hydroxy([(2r,3s,5r)-3-hydroxy-5-(4-hydroxy-5-methyl-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy)phosphoryl]oxy)phosphinic acid

C16H27N3O14P2 (547.0968)


   

12-(3,4-dihydroxyphenyl)-7,21-dihydroxy-8,16,17,18-tetramethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17-octaen-3-one

12-(3,4-dihydroxyphenyl)-7,21-dihydroxy-8,16,17,18-tetramethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17-octaen-3-one

C29H25NO10 (547.1478)


   

methyl (2s)-5-hydroxy-1-[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylate

methyl (2s)-5-hydroxy-1-[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylate

C26H29NO12 (547.169)